PMID- 27728803 OWN - NLM STAT- MEDLINE DCOM- 20170821 LR - 20220129 IS - 1878-3686 (Electronic) IS - 1535-6108 (Print) IS - 1535-6108 (Linking) VI - 30 IP - 4 DP - 2016 Oct 10 TI - SOX2 Is the Determining Oncogenic Switch in Promoting Lung Squamous Cell Carcinoma from Different Cells of Origin. PG - 519-532 LID - S1535-6108(16)30436-6 [pii] LID - 10.1016/j.ccell.2016.09.001 [doi] AB - Lung squamous cell carcinoma (LSCC) is a devastating malignancy with no effective treatments, due to its complex genomic profile. Therefore, preclinical models mimicking its salient features are urgently needed. Here we describe mouse models bearing various combinations of genetic lesions predominantly found in human LSCC. We show that SOX2 but not FGFR1 overexpression in tracheobronchial basal cells combined with Cdkn2ab and Pten loss results in LSCC closely resembling the human counterpart. Interestingly, Sox2;Pten;Cdkn2ab mice develop LSCC with a more peripheral location when Club or Alveolar type 2 (AT2) cells are targeted. Our model highlights the essential role of SOX2 in commanding the squamous cell fate from different cells of origin and represents an invaluable tool for developing better intervention strategies. CI - Copyright (c) 2016 The Authors. Published by Elsevier Inc. All rights reserved. FAU - Ferone, Giustina AU - Ferone G AD - Division of Molecular Genetics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. FAU - Song, Ji-Ying AU - Song JY AD - Division of Experimental Animal Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. FAU - Sutherland, Kate D AU - Sutherland KD AD - ACRF Stem Cells and Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Parkville, VIC 3010, Australia. FAU - Bhaskaran, Rajith AU - Bhaskaran R AD - Division of Molecular Genetics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Skolkovo Institute of Science and Technology, Skolkovo Innovation Center, Building 5, Moscow 143026, Russia. FAU - Monkhorst, Kim AU - Monkhorst K AD - Division of Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. FAU - Lambooij, Jan-Paul AU - Lambooij JP AD - Division of Molecular Genetics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. FAU - Proost, Natalie AU - Proost N AD - Division of Molecular Genetics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. FAU - Gargiulo, Gaetano AU - Gargiulo G AD - Department of Molecular Oncology, Max-Delbruck-Center for Molecular Medicine, Robert-Rossle-Strasse 10, 13092 Berlin, Germany. FAU - Berns, Anton AU - Berns A AD - Division of Molecular Genetics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Skolkovo Institute of Science and Technology, Skolkovo Innovation Center, Building 5, Moscow 143026, Russia. Electronic address: a.berns@nki.nl. LA - eng GR - 14-0433/AICR_/Worldwide Cancer Research/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Cancer Cell JT - Cancer cell JID - 101130617 RN - 0 (SOX2 protein, human) RN - 0 (SOXB1 Transcription Factors) RN - 0 (Sox2 protein, mouse) RN - EC 2.7.10.1 (Receptor, Fibroblast Growth Factor, Type 1) SB - IM CIN - Cancer Cell. 2016 Oct 10;30(4):505-507. PMID: 27728797 CIN - J Thorac Dis. 2017 Jan;9(1):E85-E86. PMID: 28203443 MH - Animals MH - Carcinoma, Squamous Cell/*genetics/metabolism/*pathology MH - Cell Proliferation/genetics MH - Disease Models, Animal MH - Gene Expression Regulation, Neoplastic MH - Humans MH - Lung Neoplasms/*genetics/metabolism/*pathology MH - Mice MH - Receptor, Fibroblast Growth Factor, Type 1/biosynthesis/genetics MH - SOXB1 Transcription Factors/*genetics MH - Transcription, Genetic MH - Tumor Microenvironment PMC - PMC5065004 EDAT- 2016/10/12 06:00 MHDA- 2017/08/22 06:00 PMCR- 2016/10/10 CRDT- 2016/10/12 06:00 PHST- 2016/03/03 00:00 [received] PHST- 2016/07/05 00:00 [revised] PHST- 2016/09/07 00:00 [accepted] PHST- 2016/10/12 06:00 [entrez] PHST- 2016/10/12 06:00 [pubmed] PHST- 2017/08/22 06:00 [medline] PHST- 2016/10/10 00:00 [pmc-release] AID - S1535-6108(16)30436-6 [pii] AID - 10.1016/j.ccell.2016.09.001 [doi] PST - ppublish SO - Cancer Cell. 2016 Oct 10;30(4):519-532. doi: 10.1016/j.ccell.2016.09.001.